RxDoctor Payments DataLook up a doctor →

Edward Glassberg, MD

MOHS-Micrographic Surgery · Long Beach, CANPI 1154387413

Payments from drug & device makers

$9,662in general payments, 2019–2025

Across 439 payments — averaging $22.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Sanofi$1K
  • Merz North America, Inc.$881
  • Novartis$718
  • LEO Pharma Inc.$676
  • Galderma Laboratories, L.p.$649
  • plus $4K from 32 others

What the payments were for

  • Speaking & faculty fees$2002%
  • Food & beverage$9,36397%
  • Education$991%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,662 in reported general payments places this provider in the 80th percentile of 144 mohs-micrographic surgery providers in California.

See all mohs-micrographic surgery providers in California

Medicare billing

Part B allowed, 2024
$512,146
Medicare patients
426
Services billed
2,544

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OdomzoSonidegib Phosphate14$177,148
Mupirocin133$909
Doxycycline Hyclate171$719
Ketoconazole27$498

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Long Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →